Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 1.0% BID in the Treatment of Non-exudative Age-Related Macular Degeneration

NCT02127463 is registered in ClinicalTrials.gov with MacuCLEAR, Inc. as lead sponsor.

NCT NCT02127463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02127463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 1.0% BID in the Treatment of Non-exudative Age-Related Macular Degeneration
Lead sponsor
MacuCLEAR, Inc.
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 30, 2014
Completion date
April 30, 2016
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-exudative age related macular degeneration